Johan A. Dobber

593 total citations
7 papers, 125 citations indexed

About

Johan A. Dobber is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Johan A. Dobber has authored 7 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 3 papers in Hematology. Recurrent topics in Johan A. Dobber's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Johan A. Dobber is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Johan A. Dobber collaborates with scholars based in Netherlands, Denmark and Sweden. Johan A. Dobber's co-authors include Arnon P. Kater, Mark‐David Levin, Mehrdad Mobasher, Sanne H. Tonino, Julie Dubois, Mels Hoogendoorn, Tom Hofland, Sabina Kersting, Eric Eldering and Iris de Weerdt and has published in prestigious journals such as Blood, Transfusion and Blood Advances.

In The Last Decade

Johan A. Dobber

7 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johan A. Dobber Netherlands	5	94	53	52	51	33	7	125
Krista M. Isaac United States	6	61 0.6×	32 0.6×	60 1.2×	20 0.4×	23 0.7×	11	105
Yiling Yu China	6	122 1.3×	39 0.7×	117 2.3×	44 0.9×	47 1.4×	8	152
Ralph Schulz Germany	5	59 0.6×	37 0.7×	35 0.7×	66 1.3×	36 1.1×	9	119
Gloria Margiotta Casaluci Italy	5	34 0.4×	60 1.1×	72 1.4×	19 0.4×	18 0.5×	11	99
Elżbieta Iskierka‐Jazdzewska Poland	7	71 0.8×	36 0.7×	84 1.6×	26 0.5×	21 0.6×	25	110
С. В. Семочкин Russia	5	44 0.5×	32 0.6×	33 0.6×	15 0.3×	44 1.3×	35	94
Jean‐Richard Eveillard France	6	51 0.5×	32 0.6×	16 0.3×	36 0.7×	79 2.4×	24	118
Mark Yan Canada	4	25 0.3×	96 1.8×	60 1.2×	29 0.6×	44 1.3×	8	148
Jennie Zhang United States	6	79 0.8×	21 0.4×	50 1.0×	16 0.3×	50 1.5×	13	103
Danielle Leão Cordeiro de Farias Brazil	6	40 0.4×	35 0.7×	33 0.6×	12 0.2×	17 0.5×	15	93

Countries citing papers authored by Johan A. Dobber

Since Specialization

Citations

This map shows the geographic impact of Johan A. Dobber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan A. Dobber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan A. Dobber more than expected).

Fields of papers citing papers by Johan A. Dobber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan A. Dobber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan A. Dobber. The network helps show where Johan A. Dobber may publish in the future.

Co-authorship network of co-authors of Johan A. Dobber

This figure shows the co-authorship network connecting the top 25 collaborators of Johan A. Dobber. A scholar is included among the top collaborators of Johan A. Dobber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan A. Dobber. Johan A. Dobber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Vos, Josephine M. I., Steven T. Pals, Willem Kraan, et al.. (2021). Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression. Leukemia & lymphoma. 63(5). 1070–1079. 8 indexed citations

2.

Ostrowski, Sisse Rye, Kazem Nasserinejad, Sabina Kersting, et al.. (2020). Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib. Leukemia & lymphoma. 61(14). 3422–3431. 1 indexed citations

3.

Weerdt, Iris de, Tom Hofland, Renate de Boer, et al.. (2019). Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. Blood Advances. 3(17). 2642–2652. 79 indexed citations

4.

Niemann, Carsten Utoft, Julie Dubois, Lisbeth Enggaard, et al.. (2019). Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial. Blood. 134(Supplement_1). 4292–4292. 3 indexed citations

5.

Weerdt, Iris de, Tom Hofland, Johan A. Dobber, et al.. (2018). First Evidence of Restoration of T and NK Cell Compartment after Venetoclax Treatment. Blood. 132(Supplement 1). 1860–1860. 5 indexed citations

6.

Kater, Arnon P., Sabina Kersting, Yvette van Norden, et al.. (2018). Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL. Blood Advances. 2(24). 3566–3571. 20 indexed citations

7.

Grommé, Monique, et al.. (2017). Multicenter study to evaluate a new enumeration method for hematopoietic stem cell collection management. Transfusion. 57(8). 1949–1955. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact